Showing 12 out of 2322 items
- Major change is coming – long-acting HIV pre-exposure prophylaxis
- Safety and effectiveness of long-acting cabotegravir for prevention in men and transgender women
- Safety and effectiveness of long-acting cabotegravir for prevention in cisgender women
- Long-acting cabotegravir - focus on transgender women
- In context – long-acting cabotegravir for HIV prevention
- Learning from a case of breakthrough infection with long-acting cabotegravir for prevention
- Programming ConnectionThe National Overdose Response Service (NORS) provides 24/7 access to virtual overdose prevention services across Canada via the telephone.
- WebinarThis third webinar in a series on syphilis in Canada will review how doxy-PEP and doxy-PrEP are currently being used to prevent syphilis, as well as explore the concerns around their use and the…